PROJECT Index
ADMALVAC
Advancing next-generation malaria vaccines
Malaria
End date:
30/06/2028
CAPTIVATE
CorrelAtes of Protective immuniTy-driven Investigation of malaria VAccine combinaTion stratEgies
Malaria
End date:
30/04/2028
Preclinical and Clinical Development
HCVIVA
Hepatitis C Virus Inactivated Vaccine Advancement
Hepatitis C
End date:
31/03/2029
NOSEVAC
Innovative nasal vaccines to prevent pathogen colonization and infection in the upper respiratory tract
Cross-cutting
End date:
30/04/2028
PfRipr5-PD
Towards the clinical development of the new asexual blood-stage malaria vaccine candidate PfRipr5 (PfRipr5-PD)
Malaria
End date:
30/09/2025
Clinical Development
ShigaPlexIM
Early clinical development of an injectable Shigella vaccine through Phase I and descending age studies with and without an adjuvant in Africa
Diarrhoeal diseases
End date:
31/12/2025
Clinical Development
ADVANCE-VAC4PM
Advancing the clinical development of placental malaria vaccines in the context of capacity building and use of digital health technologies
Malaria
End date:
31/05/2027
DGIS-PMVAC
Advancing the clinical development of placental malaria vaccines
Malaria
End date:
01/12/2027
Inno4Vac
Innovations to accelerate vaccine development and manufacture
Cross-cutting
End date:
28/02/2027
OPT-MVAC
Optimizing the delivery and uptake of malaria vaccines in countries with areas of highly seasonal transmission in West and Central Africa
Malaria
End date:
30/06/2029
PrIMAVeRa
Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance
Cross-cutting
End date:
30/09/2026
AMA1-DiCo
AMA1 Diversity Covering
Malaria
End date:
31/08/2017
Preclinical and Clinical Development
DRAIGON
Diagnosing Infections with Multi-Drug Resistant Microorganisms using AI-powered Genomic Antibiotic Susceptibility Prediction from Long-Read Sequencing Data
Cross-cutting
End date:
31/12/2027
MVC-2G
Optimising a Deployable High Efficacy Multi-Stage Vaccine for Plasmodium falciparum Malaria: 2nd Generation Malaria Vaccine Consortium
Malaria
End date:
07/09/2030
PREV_PKDL
Clinical development of a therapeutic vaccine for prevention of post-kala azar dermal leishmaniasis
Leishmaniasis
End date:
31/12/2025
Clinical Development
SEmalvac6
Biomanufacture and preclinical development of the blood-stage malaria vaccine candidate SE36/cVLP
Malaria
End date:
31/03/2027
Clinical Development
